Marimed (MRMD) Depreciation and Depletion (2016 - 2026)

Marimed (MRMD) has 11 years of Depreciation and Depletion data on file, last reported at $2.2 million in Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $2.2 million, up 22.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.5 million (up 8.97% YoY), and the FY2025 annual result was $8.1 million, up 2.53% from the prior year.
• Depreciation and Depletion climbed to $2.2 million in Q1 2026 per MRMD's latest filing, from $2.1 million in the prior quarter.
• Over five years, Depreciation and Depletion peaked at $2.2 million in Q4 2024 and troughed at $700000.0 in Q1 2022.
• A 5-year average of $1.6 million and a median of $1.8 million in 2024 frame the typical range for Depreciation and Depletion.
• The sharpest annual moves came in 2024 and 2025: Depreciation and Depletion soared 90.0% in 2024, then decreased 5.26% in 2025.
• A 5-year view of Depreciation and Depletion shows it stood at $900000.0 in 2022, then surged by 88.89% to $1.7 million in 2023, then climbed by 29.41% to $2.2 million in 2024, then retreated by 4.55% to $2.1 million in 2025, then increased by 4.76% to $2.2 million in 2026.
• Business Quant data shows MRMD's Depreciation and Depletion at $2.2 million in Q1 2026, $2.1 million in Q4 2025, and $2.1 million in Q3 2025.